Supplementary Table S1 from Safety and Efficacy of Anlotinib Hydrochloride Plus Temozolomide in Patients with Recurrent Glioblastoma

समान संसाधन

• Supplementary Table S3 from Safety and Efficacy of Anlotinib Hydrochloride Plus Temozolomide in Patients with Recurrent Glioblastoma
  द्वारा: Qingsheng Xu (17078830)
  प्रकाशित: (2025)
• Supplementary Figure S1 from A Sequential Targeting Strategy Interrupts AKT-Driven Subclone-Mediated Progression in Glioblastoma
  द्वारा: Sied Kebir (15048732)
  प्रकाशित: (2025)
• Supplementary Figure S2 from A Sequential Targeting Strategy Interrupts AKT-Driven Subclone-Mediated Progression in Glioblastoma
  द्वारा: Sied Kebir (15048732)
  प्रकाशित: (2025)
• Supplementary Figure S3 from A Sequential Targeting Strategy Interrupts AKT-Driven Subclone-Mediated Progression in Glioblastoma
  द्वारा: Sied Kebir (15048732)
  प्रकाशित: (2025)
• Supplementary Figure S4 from A Sequential Targeting Strategy Interrupts AKT-Driven Subclone-Mediated Progression in Glioblastoma
  द्वारा: Sied Kebir (15048732)
  प्रकाशित: (2025)